Emtelaak secures FRA licence to operate real estate investment fund in Egypt
Written on
Emtelaak Group has obtained a licence from Egypt's Financial Regulatory Authority for Emtelaak Real Estate Projects Fund Company to operate a real estate investment fund, opening the way for regulated property investment products.
Egypt's Emtelaak Group has obtained a licence from the Financial Regulatory Authority (FRA) for Emtelaak Real Estate Projects Fund Company to operate a real estate investment fund, as the group moves to develop investment products linked to different segments of the property market.
The licence will enable the company to develop regulated real estate investment products under its "Emtelaak Tharwa" platform, with each offering subject to the applicable legal structure, documentation and regulatory approvals.
Magdy El Yamani, chairperson of Emtelaak Fund Company, said the licence marked an important step in the company's plans to develop real estate investment solutions within established legal and regulatory frameworks. He said the company would focus on giving investors information on the underlying assets, potential sources of returns, investment periods, risks, fees and exit mechanisms for each product.
The planned offerings are expected to cover several real estate segments, including education, commercial and administrative properties, hospitality and residential assets. Depending on the investment strategy, the products could be linked either to projects under development or to existing income-generating properties. The group is also considering offerings under an "Emtelaak Future" platform targeting sectors including education and housing.
The structures under consideration will vary according to the underlying asset. Some products could focus on capital appreciation through property development and a subsequent exit, while others could generate recurring income through leasing and operations; some offerings could combine income generation with potential asset-value growth. Each offering remains subject to the required regulatory approvals.